斐济推出针头注射器计划, 以抗击200%的艾滋病毒激增, 目的是预防未来25 000例病例。 Fiji launches needle syringe programs to combat a 200% HIV surge, aiming to prevent 25,000 future cases.

斐济在2024年艾滋病毒新增病例增加200%后,启动针计划 (NSP),报告有1583例感染病例,其中青少年174例,艾滋病毒相关死亡126例. Fiji is launching Needle Syringe Programs (NSPs) after a 200% surge in new HIV cases in 2024, with 1,583 infections reported—174 among adolescents—and 126 HIV-related deaths. 在新诊断的接受治疗者中,只有711人寻求治疗,在没有干预的情况下,多达25 000人可能在四年内感染艾滋病毒。 Only 711 of the newly diagnosed sought treatment, and without intervention, up to 25,000 could be living with HIV in four years. 政府在艾滋病规划署和卫生专家的支持下表示, 国家战略计划将减少传播, 而不鼓励毒品使用, 与全球目标一致, 以结束新感染与艾滋病死亡。 The government, backed by UNAIDS and health experts, says NSPs will reduce transmission without encouraging drug use, aligning with global goals to end new infections and AIDS deaths. 该方案由内阁批准,将每年进行评估,并由联合国采购部门提供支助,以确保持续获得治疗。 The program, approved by Cabinet, will be evaluated annually and supported by UN procurement to ensure consistent access to treatments.